Abstract
BDF female mice inoculated with MXT mammary adenocarcinoma were treated for 30 days with microcapsules of the luteinizing hormone-releasing hormone (LH-RH) agonist D-Trp-6-LH-RH (releasing 25µg/day for 30 days), microcapsules of the somatostatin agonist RC-160 (liberating 25µg/day for one month), or the combination of these peptides. Bilateral surgical ovariectomy was performed in one group which served as an additional control. Tumor volume was measured weekly during the treatment period of 30 days. When tumor volume changes in the treated groups were compared to the corresponding changes in controls, the combination of D-Trp-6-LH-RH and RC-160 was the most effective in inhibiting tumor growth and approached the effect of surgical ovariectomy. At the conclusion of the experiment, tumor weights were also measured. All peptide analogs inhibited tumor weight by 42 to 63%. In the D-Trp-6-LH-RH treated group, ovarian weights and uterine weights decreased by 48% and 52%, respectively, as compared to controls. Histologically, the regressive changes in tumors caused by the treatment with RC-160, D-Trp-6-LH-RH and their combination were characterized by the coexistence of apoptosis (programmed cell death) and coagulation necrosis. The transition of apoptosis into coagulation necrosis was a common finding. The term ‘apoptotic index’ is proposed for the ratio of tumorous glands containing apoptotic cells. The apoptotic index was higher in the treated groups than in the control.
References
Schally AV, Comaru-Schally AM: Use of Luteinizing Hormone-Releasing Hormone analogs in the treatment of hormone dependent tumors. Semin Reprod Endocrinol 5: 389–398, 1987
Schally AV: Oncological applications of somatostatin analogs. Cancer Res 48: 6977–6985, 1988
Schally AV, Bajusz S, Redding TW, Zalatnai A, Comaru-Schally AM: Analogs of LH-RH. The present and the future. In: Vickery BH, Luenefeld B: GnRH analogues in cancer and human reproduction. MTP Press, Lancaster/Boston, 1989
Gonzalez-Barcena D, Rangel-Garcia N, Perez-Sanchez PL, Gutierrez-Damperio C, Garcia-Carrasco R, Comaru-Schally AM, Schally AV: Response of advanced adenocarcinoma of pancreas to D-Trp-6-LH-RH. Lancet ii, 154, 1989
Schally AV, Redding TW: Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Proc Natl Acad Sci USA 84: 7275–7279, 1987
Fekete M, Zalatnai A, Comaru-Schally AM, Schally AV: Membrane receptors for peptides in experimental and human pancreatic cancers. Pancreas 4: 521–528, 1989
Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM: Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313: 231–233, 1985
Scambia G, Benedetti-Panici P, Baiocchi G, Perrone L, Iacobelli S, Mancuso S: Antiproliferative effects of somatostatin analogs SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol 114: 306–308, 1988
Seytono-Han B, Henkelman MS, Foekens JA, Klijn JGM: Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res 47: 1566–1570, 1987
Redding TW, Fekete M, Schally AV: Direct inhibition of the MT-5 rat mammary tumor cell line by somatostatin analog RC-160. Abstract, Endocrine Society meeting, New Orleans, June, 1988, No. 603, p 171
Sharoni Y, Basin E, Miinster A, Levy J, Schally AV: Inhibition of growth of human mammary tumor cells by potent antagonists of Luteinizing Hormone-Releasing Hormone. Proc Natl Acad Sci USA 86: 1989, in press
Gullino PM: The regression process in hormone-dependent mammary carcinomas. In: Iacobelli S,et al.: Hormones and Cancer. Raven Press, New York, 1980, pp 271–279
Szende B, Zalatnai A, Schally AV: Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proc Natl Acad Sci USA 86: 1643–1647, 1989
Watson C, Medina D, Clark JH: Estrogen receptor characterization in a transplantable mouse mammary tumor. Cancer Res 37: 3344–3348, 1977
Srkalovic G, Szende B, Redding TW, Groot K, Schally AV: Receptors for D-Trp-6-luteinizing hormone-releasing hormone, somatostatin and insulin-like growth factor-I in MXT mouse mammary carcinoma. Proc Soc Exp Biol Med 192: dec 1989
Schally AV, Redding TW, Comaru-Schally AM: Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH. Prostate 4: 545–552, 1983
Redding TW, Schally AV: Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp-6-LH-RH. Proc Natl Acad Sci USA 80: 6509–6512, 1983
Redding TW, Schally AV: Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones. Proc Natl Acad Sci USA 80: 1078–1082, 1983
Redding TW, Schally AV: Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proc Natl Acad Sci USA 81: 248–252, 1984
Redding TW, Schally AV: Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 80: 1459–1462, 1983
Gullino PM, Grantham FH, Losonczy I, Berghoffer B: Mammary tumor regression, I. Physiopathologic characteristics of hormone-dependent tissue. J Natl Cancer Inst 49: 1333–1348, 1972
Gullino PM, Lanzerotti RH: Mammary tumor regression, II. Autophagy of neoplastic cells. J Natl Cancer Inst 49: 1349–1356, 1972
Kerr JFR, Wyllie AH, Currie AR: Apoptosis: basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257, 1972
Searle J, Lawson TA, Abbott PJ, Harmon B, Kerr JFR: An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol 116: 129–138, 1975
Wyllie AH: The biology of cell death in tumors. Anticancer Res 5: 131–136, 1985
Wyllie AH: What is apoptosis? Histopathology 10: 995–998, 1986
Crass RA, Morgan RGH: The effects of long-term feeding of soybean flour diets on pancreatic growth in the rat. Br J Nutr 47: 119–126, 1982
Oates PS, Bruce NB, Morgan RGH: Pancreatic blood flow in the rat during enlargement, involution and cholecystokinin treatment. Am J Physiol 247: G457-G462, 1984
Oates PS, Morgan RGH, Light AM: Cell death (apoptosis) during pancreatic involution after raw soya flour feeding in the rat. Am J Physiol 198: G9-G14, 1986
Evans GS, Chandler JA: Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 11: 339–351, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Szende, B., Lapis, K., Redding, T.W. et al. Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin. Breast Cancer Res Tr 14, 307–314 (1989). https://doi.org/10.1007/BF01806302
Issue Date:
DOI: https://doi.org/10.1007/BF01806302